Angiogenesis and ophthalmic disease (original) (raw)

• Lee P, Wang CC, Adamis AP. Ocular neovascularization: An epidemiological review. Surv Ophthalmol 1998; 43: 245–69.
  Article PubMed CAS Google Scholar
• Huang AJW, Watson BD, Hernandez E, Tseng SCG. Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization. Ophthalmology 1988; 95: 228–35.
  PubMed CAS Google Scholar
• Huang AJW, Watson BD, Hernandez E, Tseng SCG. Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization. Ophthalmology 1988; 95: 228–35.
  PubMed CAS Google Scholar
• Arentsen JJ. Corneal neovascularization in contact lens wearers. Int Ophthalmol Clin 1986; 26: 15–23.
  PubMed CAS Google Scholar
• Kruse FE, Chen JJY, Tsai RJF, Tseng SCG. Conjunctival transdifferentiation is due to the incomplete removal of limbal basal epithelium. Invest Ophthalmol Vis Sci 1990; 31: 1903–13.
  PubMed CAS Google Scholar
• Klintworth GK. Corneal Angiogenesis. A Comprehensive and Critical Review, 1st edition. New York: Springer-Verlag 1990; 26.
  Google Scholar
• Amano S, Rohan R, Kuroki M et al. Requirement for vascular endothelial growth factor in wound-and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 1998; 39: 18–22.
  PubMed CAS Google Scholar
• Cursifen C, Hofman-Rummelt C, Kuche MNGOH. VEGF-immunoreactivity in human corneal buttons with neovascularization. ARVO abstracts. Invest Ophthalmol Vis Sci 1998; 39: S3418.
  Google Scholar
• Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease. Trans Ophthalmol Soc UK 1948; 68: 137–80.
  Google Scholar
• Ashton N. Retinal vascularization in health and disease. Am J Ophthlamol 1957; 44: 7–24.
  CAS Google Scholar
• Wise GN. Retinal neovascularization. Trans Am Ophthalmol Soc 1956; 54: 729–826.
  PubMed CAS Google Scholar
• Nork TM, Tso MO, Duvall J, Hayreh SS. Cellular mechanisms of iris neovascularization secondary to retinal vein occlusion. Arch Ophthalmol 1989; 107: 581–6.
  PubMed CAS Google Scholar
• Schultze RR. Rubeosis iridis. Am J Ophthalmol 1967; 63: 487–95.
  Google Scholar
• Shima DT, Gougos A, Miller JW et al. Cloning and mRNA expression of VEGF in ischemic retinas of Maccaca fasicularis. Invest Ophthalmol Vis Sci 1996; 37: 1334–40.
  PubMed CAS Google Scholar
• Miller J, Adamis AP, Shima DT et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994; 145: 574–84.
  PubMed CAS Google Scholar
• Adamis AP, Shima DT, Tolentino M et al. Inhibition of VEGF prevents retinal ischemia-associated iris neovascularization in a primate. Arch Ophthalmol 1996; 114: 66–71.
  PubMed CAS Google Scholar
• Tolentino MJ, Miller JW, Gragoudas ES et al. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol 1996; 114: 964–70.
  PubMed CAS Google Scholar
• Pe'er J, Shweiki D, Itin A et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995; 72: 638–45.
  PubMed Google Scholar
• Aiello LP, Avery RL, Arrigg PG et al. Vascular endothelial growth factor in ocular fluid of patients wth diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480–87.
  Article PubMed CAS Google Scholar
• Pournaras CJ, Tsacopoulos M, Strommer K et al. Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology 1990; 97: 1329–33.
  PubMed CAS Google Scholar
• Pournaras CJ, Miller JW, Gragoudas ES et al. Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. Arch Ophthalmol 1997; 115: 1553–8.
  PubMed CAS Google Scholar
• Imesch PD, Bindley CD, Wallow IH. Clinicopathologic correlation of intraretinal microvascular abnormalities. Retina 1997; 17: 321–9.
  PubMed CAS Google Scholar
• Tolentino MJ, Miller JW, Gragoudas ES et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996; 103: 1820–8.
  PubMed CAS Google Scholar
• The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: The second report of the diabetic retinopathy study findings. Ophthalmology 1978; 85: 82–92.
  Google Scholar
• Federman JL, Boyer D, Lanning R, Breit P. An objective analysis of proliferative diabetic retinopathy before and after pars plana vitrectomy. Ophthalmology 1979; 86: 276–82.
  PubMed CAS Google Scholar
• Schroder S, Palinski, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary non-perfusion, and neovascularization in diabetic retinopathy. Am J Pathol 1991; 139: 81–00.
  PubMed CAS Google Scholar
• McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 1995; 147: 642–53.
  PubMed CAS Google Scholar
• Miyamoto K, Ogura Y. Role of leukocytes in diabetic microcirculatory disturbances. Microvas Res 1997; 54: 43–8.
  Article CAS Google Scholar
• Braun RD, Fisher TC, Meiselman HJ, Hatchell DL. Decreased deformability of polymorphonuclear leukocytes in diabetic cats. Microcirculation 1996; 3: 271–8.
  PubMed CAS Google Scholar
• Kelly LW, Barden CA, Tiedeman JS, Hatchell DL. Alterations in viscosity and filterability of whole blood and blood cell subpopulations in diabetic cats. Exp Eye Res 1993; 56: 341–7.
  Article PubMed CAS Google Scholar
• Dobbie JG, Kwaan HC, Colwell J, Suwanwela N. Role of platelets in pathogenesis of diabetic retinopathy. Arch Ophthalmol 1974; 91: 107–9.
  PubMed CAS Google Scholar
• Diacovo TG, Puri KD, Warnock RA et al. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 1996; 273: 252–5.
  PubMed CAS Google Scholar
• Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843–5.
  Article PubMed CAS Google Scholar
• Aiello LP, Northrup JM, Keyt BA et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Archives of Ophthalmology 1995; 113: 1538–44.
  PubMed CAS Google Scholar
• Takagi H, King GL, Robinson GS et al. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Opthalmol Vis Sci 1996; 37: 2165–76.
  CAS Google Scholar
• Xia P, Aiello LP, Ishii H et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 1996; 98: 2018–26.
  PubMed CAS Google Scholar
• Thieme H, Aiello LP, Takagi H et al. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 1995; 44: 98–103.
  PubMed CAS Google Scholar
• Okamoto N, Tobe T, Hacket SF et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina. A new model of intraretinal and subretinal neovascularization. Am J Pathol 1997; 151: 281–91.
  PubMed CAS Google Scholar
• Aiello LP, Pierce EA, Foley ED et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995; 92: 10457–61.
  Article PubMed CAS Google Scholar
• Takagi H, King GL, Aiello LP. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 1996; 45: 1016–23.
  PubMed CAS Google Scholar
• Adamis AP, Miller J, Bernal M-T et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118: 445–50.
  PubMed CAS Google Scholar
• Shima D, Adamis AP, Ferrara N et al. Hypoxic induction of endothelial cell growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med 1995; 2: 182–93.
  Google Scholar
• Malecaze F, Clamens S, Simorre-Pinatel V et al. Detection of vascular endothelial growth factor messanger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994; 112: 1476–82.
  PubMed CAS Google Scholar
• Hata Y, Duh E, Zhang K et al. Transcriptoin factors sp1 and sp3 affect vascular endothelial growth factor receptor KDR expression through a novel recognition sequence. J Biol Chem 1998; 273: 19294–303.
  Article PubMed CAS Google Scholar
• Ishii H, Jirousek MR, Koya D et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996; 272: 728–31.
  PubMed CAS Google Scholar
• Danis RP, Bingaman DP, Jirousek M, Yang Y. Inhibition of intraocular neovascularizatoin caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531. Invest Ophthalmol Vis Sci 1998; 39: 171–9.
  PubMed CAS Google Scholar
• Aiello LP, Bursell SE, Clermont A et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997; 46: 1473–80.
  PubMed CAS Google Scholar
• Hammes H-P, Brownlee M, Jonczyk A et al. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nature Med 1996; 2: 529–33.
  Article PubMed CAS Google Scholar
• Luna J, Tobe T, Mousa SA et al. Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. Lab Invest 1998; 75: 563–73.
  Google Scholar
• Friedlander M, Brooks PC, Shaffer RW et al. Definition of two angiogenic pathways by distinct alpha v integrins. Science 1995; 270: 1500–2.
  PubMed CAS Google Scholar
• Smith LE, Kopchick JJ, Chen W et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 1997; 276: 1706–9.
  Article PubMed CAS Google Scholar
• Freund KB, Yannuzzi LA, Sorenson JA. Age-related macular degeneration of choroidal neovascularization. Am J Ophthalmol 1993; 115: 786–91.
  PubMed CAS Google Scholar
• Group MPS. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol 1990; 108: 825–31.
  Google Scholar
• Sarks SH. Ageing and degeneration in the macular region: A clinico-pathological study. Br J Ophthalmol 1976; 60: 324–41.
  PubMed CAS Google Scholar
• Chen JC, Fitzke FW, Pauleikhoff D, Bird AC. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci 1992; 33: 334–40.
  PubMed CAS Google Scholar
• Green WR, Enger C. Age-related macular degeneration histopathological studies. Ophthalmology 1992; 100: 1519–35.
  Google Scholar
• Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. [Review]. Surv Ophthalmol 1988; 32: 375–413.
  Article PubMed CAS Google Scholar
• Allikmets R, Shroyer NF, Singh N et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997; 277: 1805–7.
  Article PubMed CAS Google Scholar
• Lopez PF, Sippy BD, Lambert HM et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996; 37: 855–68.
  PubMed CAS Google Scholar
• Ishibashi T, Hata Y, Yoshikawa H et al. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 1997; 235: 159–67.
  Article PubMed CAS Google Scholar
• Friedlander M, Brooks PC, Shaffer RW et al. Definition of two angiogenic pathways by distinct alpha v integrins. Science 1995; 270: 1500–2.
  PubMed CAS Google Scholar
• Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439–42.
  Article PubMed CAS Google Scholar
• Stone J, Itin A, Alon T et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995; 15: 4738–47.
  PubMed CAS Google Scholar
• Zhang Y, Stone J. Role of astrocytes in the control of developing retinal vessels. Invest Ophthalmol Vis Sci 1997; 38: 1653–66.
  PubMed CAS Google Scholar
• Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125: 1591–8.
  PubMed CAS Google Scholar
• Alon T, Hemo I, Itin A et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med 1995; 1: 1024–8.
  Article PubMed CAS Google Scholar
• Benjamin LE, Golijanin D, Itin A et al. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 1999; 103: 159–65.
  Article PubMed CAS Google Scholar
• Williamson JR, Chang K, LeJeune W et al. Links between retinal vascular dysfunction induced by elevated glucose levels and VEGF. ARVO abstracts. Invest Ophthalmol Vis Sci 1996; 37: S47.
  Google Scholar
• Miyamoto K, Ogura Y, Hamada M et al. In vivo quantification of leukocyte behavior in the retina during endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1996; 37: 2708–15.
  PubMed CAS Google Scholar